234 related articles for article (PubMed ID: 26678309)
1. Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution.
Nozaki Y; Fujita K; Wada K; Yoneda M; Shinohara Y; Imajo K; Ogawa Y; Kessoku T; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
BMC Gastroenterol; 2015 Dec; 15():177. PubMed ID: 26678309
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH.
Amrutkar M; Cansby E; Nuñez-Durán E; Pirazzi C; Ståhlman M; Stenfeldt E; Smith U; Borén J; Mahlapuu M
FASEB J; 2015 Apr; 29(4):1564-76. PubMed ID: 25609431
[TBL] [Abstract][Full Text] [Related]
4. LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).
Soares e Silva AK; de Oliveira Cipriano Torres D; dos Santos Gomes FO; dos Santos Silva B; Lima Ribeiro E; Costa Oliveira A; dos Santos LA; de Lima Mdo C; Pitta Ida R; Peixoto CA
PLoS One; 2015; 10(4):e0123787. PubMed ID: 25875942
[TBL] [Abstract][Full Text] [Related]
5. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
7. Suppressive Role of PPARγ-Regulated Endothelial Nitric Oxide Synthase in Adipocyte Lipolysis.
Yamada Y; Eto M; Ito Y; Mochizuki S; Son BK; Ogawa S; Iijima K; Kaneki M; Kozaki K; Toba K; Akishita M; Ouchi Y
PLoS One; 2015; 10(8):e0136597. PubMed ID: 26317347
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.
Yang M; Liu Q; Huang T; Tan W; Qu L; Chen T; Pan H; Chen L; Liu J; Wong CW; Lu WW; Guan M
Theranostics; 2020; 10(24):10874-10891. PubMed ID: 33042259
[No Abstract] [Full Text] [Related]
9. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
10. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance.
Kim HY; Park SY; Lee MH; Rho JH; Oh YJ; Jung HU; Yoo SH; Jeong NY; Lee HJ; Suh S; Seo SY; Cheong J; Jeong JS; Yoo YH
J Hepatol; 2015 Aug; 63(2):477-85. PubMed ID: 25646886
[TBL] [Abstract][Full Text] [Related]
11. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
12. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.
Cabou C; Cani PD; Campistron G; Knauf C; Mathieu C; Sartori C; Amar J; Scherrer U; Burcelin R
Diabetes; 2007 Dec; 56(12):2872-7. PubMed ID: 17804761
[TBL] [Abstract][Full Text] [Related]
13. JIP3 knockout protects mice against high fat diet-induced liver injury.
Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
[TBL] [Abstract][Full Text] [Related]
14. "Non alcoholic fatty liver disease and eNOS dysfunction in humans".
Persico M; Masarone M; Damato A; Ambrosio M; Federico A; Rosato V; Bucci T; Carrizzo A; Vecchione C
BMC Gastroenterol; 2017 Mar; 17(1):35. PubMed ID: 28264657
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
Zhang Y; Wu B; Zhang H; Ge X; Ying S; Hu M; Li W; Huang Y; Wang L; Chen C; Shan X; Liang G
J Cell Mol Med; 2018 Feb; 22(2):936-947. PubMed ID: 29077272
[TBL] [Abstract][Full Text] [Related]
16. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
[TBL] [Abstract][Full Text] [Related]
17. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
18. eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH.
Sheldon RD; Meers GM; Morris EM; Linden MA; Cunningham RP; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E605-E616. PubMed ID: 31361543
[TBL] [Abstract][Full Text] [Related]
19. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
[TBL] [Abstract][Full Text] [Related]
20. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]